Simona Bossolasco
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Two-year efficacy and safety of long-acting cabotegravir and rilpivirine in the SCohoLART study.
Journal: AIDS (London, England)
Published: February 19, 2026
Clostridioides difficile infection following self-directed post-exposure antibiotic use for STI prevention.
Journal: Sexually transmitted infections
Published: March 13, 2025
Non-liver Malignancies as Main Cause of Mortality After HCV Eradication Among People Living With HIV: Erratum.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 10, 2025
Sexually transmitted infections in MSM with tenofovir/emtricitabine-resistant or cabotegravir-resistant HIV.
Journal: AIDS (London, England)
Published: November 23, 2024
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition.
Journal: AIDS and behavior
Published: March 12, 2024
Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysis.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: February 24, 2024
Performance evaluation of a self-administered point-of-care test for anal HPV screening in PrEP users: data from a community-based PrEP service.
Journal: Sexually transmitted infections
Published: July 24, 2023
Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis.
Journal: Pathogens (Basel, Switzerland)
Published: April 03, 2023
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study.
Journal: Sexually transmitted diseases
Published: February 02, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting.
Journal: International journal of antimicrobial agents
Published: December 27, 2022
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment.
Journal: Journal of medical virology
Published: July 09, 2022
Last Updated: 09/26/2026